Citius Pharmaceuticals, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration
Citius Pharmaceuticals, Inc. (CTXR) had Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration of $29.00 million as of 2025-09-30, per its 10-K filed 2025-12-23.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration · last filed 2025-12-23
- 2025-09-30: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $29.00M.
- 2024-09-30: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $35.00M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration |
|---|---|
| 2025-09-30 | $29.00M 10-K · filed 2025-12-23 |
| 2024-09-30 | $35.00M 10-K · filed 2024-12-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |